(Q28186455)
Statements
Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience (English)
0 references
December 2003
0 references
26
0 references
12
0 references
3288-95
0 references